ATED Therapeutics
Greenwich, US · Founded 2022 · Israel corporation
Founders & leadership
JC
Joseph ChiarelliExecutive
JR
Jeff R. SwarzNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$670K disclosed across 1 round · 2024
▶$670KraisedApr 2026 · 13 investors · Other Health CareRule 506(b)
▶$670KraisedApr 2026 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph ChiarelliExecutive Officer, Director
- Jeff R. SwarzExecutive Officer, Director
- Offering amount
- $670K
- Amount sold
- $670K
- Minimum investment
- $25K
- First sale
- Oct 2024
- Incorporated
- Corporation, Israel, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has ATED Therapeutics raised?
- ATED Therapeutics has disclosed $670K raised across 1 round.
- Where is ATED Therapeutics headquartered?
- ATED Therapeutics is headquartered in Greenwich, US.